Of the top 20, Novo and Lilly were among only six companies that witnessed declines in their market value in the third ...
This report from GlobalData will help you better understand the potential impact of Trump 2.0 on the Automotive industry.
GlobalData (GB:DATA) has released an update. GlobalData Plc has executed a share buyback, purchasing 100,000 of its ordinary ...
GlobalData reports that at least five pipeline devices are now in the regulatory approval process across the US and Europe, ...
Slowing electric-vehicle adoption is likely to accelerate even further as President-elect Donald Trump delivers on his ...
With Donald Trump securing his return to the White House for a second term, we explore what his second term could mean for ...
The global biopharmaceutical market saw a 2% increase in market capitalization in Q3 2024, led by growth from Bristol-Myers ...
Eli Lilly and Johnson & Johnson are seeking label expansions for Omvoh and Tremfya, respectively, in Crohn’s disease ...
Demis Hassabis, joint winner of the Nobel Prize in Chemistry 2024, shared insights on AI at the FT Pharma and Biotech Summit.
A previous version of this article incorrectly said that U.S. restaurant spending is expected to reach $1.22 billion in 2024, ...
Lord Vallance stated the government sees investment, innovation, and public-private partnership as crucial to UK healthcare.
In Canada pharmaceutical industry, there were two private equity deals announced in Q3 2024, worth a total value of $4.2m, according to GlobalData's Deals Database.